Erectile dysfunction

  • Max Hilz
  • , Ruihao Wang
  • , David B. Vodušek

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Male erectile dysfunction (ED) increases with age and afflicts 52% of the 40-70 year old men. Neurological, endocrine, vascular, inflammatory, metabolic diseases, traumata, tumorous causes, illicit or "recreational "drugs, numerous prescription drugs, and psychological or psychiatric causes may induce ED. Diabetes mellitus is a leading cause of ED. ED can be the first sign of diabetes but also of coronary artery disease and thus requires a careful evaluation. In addition to a detailed history, ED patients need a general physical examination and may need additional urological, internal medicine, endocrinological-andrological, psychiatric and neurological assessment. Phosphodiesterase type 5 inhibitors should only be prescribed to patients at low cardiovascular risk. Various side effects and strict contraindications, such as treatment with nitrates, NO-donors, or alpha-blockers, and several others must be considered. Other ED treatments include lifestyle changes, where appropriate testosterone replacement, psychosexual counselling, intracavernous or intra-urethral prostaglandin E1 applications, vacuum erection pumps, constrictions rings, penile arterial reconstructive surgery, and penile prosthesis.

Original languageEnglish
Title of host publicationAutonomic Disorders in Clinical Practice
PublisherSpringer International Publishing
Pages291-315
Number of pages25
ISBN (Electronic)9783031430367
ISBN (Print)9783031430350
DOIs
StatePublished - 6 Dec 2023

Keywords

  • Cardiovascular disease
  • Diabetes mellitus
  • Erectile dysfunction
  • Impotence
  • Intracavernous prostaglandin E1 injections
  • Nitrates
  • Penile prosthesis
  • Phosphodiesterase type 5 inhibitors
  • Vacuum pumps

Fingerprint

Dive into the research topics of 'Erectile dysfunction'. Together they form a unique fingerprint.

Cite this